Which bronchodilator should not be a first line drug for acute bronchospasm?
•
2 min read
According to the National Institutes of Health, long-acting bronchodilators are not used for treating acute bronchospasm, as their slow onset of action makes them ineffective for a sudden, life-threatening asthma attack. Understanding which bronchodilator should not be a first line drug for acute bronchospasm is a critical safety measure that can prevent serious adverse events.
